Based on the new nomenclature, LGMD2A, LGMD2B, LGMD2C, and LGMD2D were renamed as LGMD R1 calpain3-related, LGMD R2 dysferlin-related, LGMD R5 γ-sarcoglycan-related, and LGMD R3 α-sarcoglycan-related, respectively.3 The gene discussed is CAPN3; the disease is limb-girdle muscular dystrophy.